From: Eisinger, Robert (NIH/NIAID) [E] on behalf of Fauci, Anthony (NIH/NIAID) [E]

Sent: Thu, 9 Apr 2020 21:24:50 +0000

To: Fauci, Anthony (NIH/NIAID) [E]

Subject: FW: COVID 19 Briefing Document and COVID Vaccine Overview
Attachments: Overview of COVID-19 Vaccine Development_April9.pdf, Briefing Document

NIAID Involvement with Pharma in COVID19_April 9_with table.pdf

The email below is from Larry Corey.

Robert W. Eisinger, Ph.D.

Special Assistant for Scientific Projects

Immediate Office of the Director

National Institute of Allergy and Infectious Diseases
National Institutes of Health

31 Center Drive, Room 7A-03

Bethesda MD 20892

Telephone: ___— J
Email: —<—_____ 09

From: Corey MD, Larryf 8) >

Sent: Thursday, April 9, 2020 3:50 PM

To: Fauci, Anthony (NIH/NIAID) [EJ ________ ©) @}>; Conrad, Patricia (NIH/NIAID) [E]
Se) OF; Marston, Hilary (NIH/NIAID) [EJ >

Cc: Mascola, John (NIH/VRC} [tO 8) Erbelding, Emily (NIH/NIAID) (E]
50) >; Dieffenbach, Carl (NIH/NIAID) [E] }>; Lane, Cliff

(NIH/NIAID) 7 O10

Subject: COVID 19 Briefing Document and COVID Vaccine Overview

 

   

Tony,

We are sending you two documents relating to our strategy for COVID vaccine development . The

 
